Page last updated: 2024-09-04

olmesartan and Angor Pectoris

olmesartan has been researched along with Angor Pectoris in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amano, T; Harada, K; Ichimiya, S; Ishii, H; Kanashiro, M; Kobayashi, M; Kurebayashi, N; Marui, N; Murohara, T; Sone, T; Suzuki, S; Tsuboi, H; Uetani, T; Yoshikawa, D	1
Hatanaka, K; Hina, K; Hirohata, A; Hirohata, S; Hirose, E; Ishizawa, M; Kawamura, H; Komatsubara, I; Kusachi, S; Miyoshi, T; Murakami, M; Murakami, T; Ohe, T; Ohkawa, K; Sato, S; Yamaji, H; Yamamoto, K; Yamawaki, H	1

Trials

2 trial(s) available for olmesartan and Angor Pectoris

Article	Year
Impact of angiotensin II receptor blocker therapy (olmesartan or valsartan) on coronary atherosclerotic plaque volume measured by intravascular ultrasound in patients with stable angina pectoris. The American journal of cardiology, 2013, Aug-01, Volume: 112, Issue:3 Topics: Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Combined Modality Therapy; Coronary Artery Disease; Disease Progression; Double-Blind Method; Female; Humans; Hypertension; Image Interpretation, Computer-Assisted; Imidazoles; Long-Term Care; Male; Middle Aged; Tetrazoles; Ultrasonography, Interventional; Valine; Valsartan	2013
Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial. Journal of the American College of Cardiology, 2010, Mar-09, Volume: 55, Issue:10 Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Imidazoles; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Survival Rate; Tetrazoles; Ultrasonography, Interventional	2010

Article

Year

Impact of angiotensin II receptor blocker therapy (olmesartan or valsartan) on coronary atherosclerotic plaque volume measured by intravascular ultrasound in patients with stable angina pectoris.

The American journal of cardiology, 2013, Aug-01, Volume: 112, Issue:3

Topics: Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Combined Modality Therapy; Coronary Artery Disease; Disease Progression; Double-Blind Method; Female; Humans; Hypertension; Image Interpretation, Computer-Assisted; Imidazoles; Long-Term Care; Male; Middle Aged; Tetrazoles; Ultrasonography, Interventional; Valine; Valsartan

2013

Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.

Journal of the American College of Cardiology, 2010, Mar-09, Volume: 55, Issue:10

Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Imidazoles; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Survival Rate; Tetrazoles; Ultrasonography, Interventional

2010